Form D · Hedge Fund
Welch Life Sciences Fund, L.P.
New York, NY · CIK 0001461247
Offering snapshot reported Apr 10, 2012 · SEC filing
- Reported sold
- $27.8M Indefinite offering
- Investors reported
- 18 Form D · investor count
- Minimum accepted
- $1M Reported outside-investor minimum
- First sale
- May 31, 2000 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 10, 2012 | Amendment | $27,779,000 | $0vs Apr 11, 2011 | 18 | SEC filing |
| Apr 11, 2011 | Amendment | $27,779,000 | $0vs Apr 29, 2010 | 18 | SEC filing |
| Apr 29, 2010 | Amendment | $27,779,000 | $0vs Apr 13, 2009 | 18 | SEC filing |
| Apr 13, 2009 | Initial | $27,779,000 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06, 3C, 3C.1
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-130157
Source: Form D, filed Apr 10, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Leighton B. Welch | Executive |
| Christopher Welch | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:New York, NY, 10016